Apple cider vinegar consumption improves fasting blood sugar, HbA1c and Total cholesterol

Overall, 25 clinical trials (33 arms) comprising 1320 adults were entered in this study. ACV consumption could significantly improve the levels of FBG (-21.20 mg/dl; 95% CI: -32.31 to -2.21; I2: 95.8%), HbA1c (-0.91mg/dl; 95% CI: -1.62 to -0.21; I2: 98.9%), and TC (-6.72 mg/dl; 95% CI: -12.91 to -0.53; I2:50.8%). No significant results were observed for BMI, HOMA-IR, serum insulin, TG, LDL-C, and HDL-C. Subgroup analysis showed a significant decrease in FBG, HbA1c, TC, and TG in diabetic patients. In this type of analysis, ACV consumption significantly reduced FBG levels when administered for both duration subgroups (≥12 and <12 weeks). Moreover, in the subgroup analysis based on duration, TG concentration was significantly decreased following ACV consumption for ≥ 12 weeks. This meta-analysis showed that consumption of ACV has a favorable effect in decreasing some CMS risk factors including FBG, HbA1c, and TC.

Sahar Dadkhah Tehrani, Mahdi Keshani, Mohammad Hossein Rouhani, Seyed Adel Moallem, Mohammad Bagherniya and Amirhossein Sahebkar.The effects of apple cider vinegar on cardiometabolic risk factors: A systematic review and meta-analysis of clinical trials. (E-pub Abstract Ahead of Print). DOI: 10.2174/0929867331666230822102021

Consumption, apple, cider, vinegar, improves, cardiometabolic, risk, factors, including, fasting, blood sugar, HbA1c, Total cholesterol, Current Medicinal Chemistry, Apple cider vinegar, Cardiometabolic risk factors, Fasting blood glucose, HbA1C, Cholesterol, Meta-analysis